drugset / Trial / NCT00833989
Safety Escalating Repeat IV, in Stroke Patients
RandomizedParallel-groupSingle-blindOther
Summary
The purpose of this study is to is to test increasing repeat doses of GSK249320 compared to placebo in patients with stroke.
Timeline
- Start
- 2009-07-08
- Primary completion
- 2011-01-31
- Completion
- 2011-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GSK249320 | Monoclonal antibody | 1 mg/kg | Intravenous |
| Subject | GSK249320 | Monoclonal antibody | 5 mg/kg | Intravenous |
| Subject | GSK249320 | Monoclonal antibody | 15 mg/kg | Intravenous |